213 related articles for article (PubMed ID: 24123957)
1. Cytotoxicity of PVPAC-treated bovine pericardium: a potential replacement for glutaraldehyde in biological heart valves.
Barros JA; Filippin-Monteiro FB; de Oliveira EM; Campa A; Catalani LH; Pitombo Rde N; Polakiewicz B
J Biomed Mater Res B Appl Biomater; 2014 Apr; 102(3):574-82. PubMed ID: 24123957
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic acellular detoxified glutaraldehyde cross-linked bovine pericardium for tissue engineering.
Mathapati S; Bishi DK; Guhathakurta S; Cherian KM; Venugopal JR; Ramakrishna S; Verma RS
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1561-72. PubMed ID: 23827609
[TBL] [Abstract][Full Text] [Related]
3. Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material.
Grabenwöger M; Sider J; Fitzal F; Zelenka C; Windberger U; Grimm M; Moritz A; Böck P; Wolner E
Ann Thorac Surg; 1996 Sep; 62(3):772-7. PubMed ID: 8784007
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity and endothelial cell adhesion of lyophilized and irradiated bovine pericardium modified with silk fibroin and chitosan.
Rodas AC; Polak R; Hara PH; Lee EI; Pitombo RN; Higa OZ
Artif Organs; 2011 May; 35(5):502-7. PubMed ID: 21595719
[TBL] [Abstract][Full Text] [Related]
5. Effect of freeze-drying on the mechanical, physical and morphological properties of glutaraldehyde-treated bovine pericardium: evaluation of freeze-dried treated bovine pericardium properties.
Borgognoni CF; Maizato MJ; Leirner AA; Polakiewicz B; Beppu MM; Higa OZ; Pitombo RN
J Appl Biomater Biomech; 2010; 8(3):186-90. PubMed ID: 21337310
[TBL] [Abstract][Full Text] [Related]
6. A universal strategy for the construction of polymer brush hybrid non-glutaraldehyde heart valves with robust anti-biological contamination performance and improved endothelialization potential.
Yu T; Zheng C; Chen X; Pu H; Li G; Jiang Q; Wang Y; Guo Y
Acta Biomater; 2023 Apr; 160():87-97. PubMed ID: 36812953
[TBL] [Abstract][Full Text] [Related]
7. Detoxification and endothelialization of glutaraldehyde-fixed bovine pericardium with titanium coating: a new technology for cardiovascular tissue engineering.
Guldner NW; Jasmund I; Zimmermann H; Heinlein M; Girndt B; Meier V; Flüss F; Rohde D; Gebert A; Sievers HH
Circulation; 2009 Mar; 119(12):1653-60. PubMed ID: 19289635
[TBL] [Abstract][Full Text] [Related]
8. Alkaline phosphatase activity of glutaraldehyde-treated bovine pericardium used in bioprosthetic cardiac valves.
Maranto AR; Schoen FJ
Circ Res; 1988 Oct; 63(4):844-8. PubMed ID: 3139323
[TBL] [Abstract][Full Text] [Related]
9. Fixation of Bovine Pericardium-Based Tissue Biomaterial with Irreversible Chemistry Improves Biochemical and Biomechanical Properties.
Tam H; Zhang W; Infante D; Parchment N; Sacks M; Vyavahare N
J Cardiovasc Transl Res; 2017 Apr; 10(2):194-205. PubMed ID: 28213846
[TBL] [Abstract][Full Text] [Related]
10. In vitro comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves.
Aguiari P; Iop L; Favaretto F; Fidalgo CM; Naso F; Milan G; Vindigni V; Spina M; Bassetto F; Bagno A; Vettor R; Gerosa G
Biomed Mater; 2017 Feb; 12(1):015021. PubMed ID: 28157718
[TBL] [Abstract][Full Text] [Related]
11. Detoxified glutaraldehyde cross-linked pericardium: tissue preservation and mineralization mitigation in a subcutaneous rat model.
Valente M; Pettenazzo E; Thiene G; Molin GM; Martignago F; De Giorgi G; Gatti AM; Giaretta A; Pasquino E; Talenti E; Rinaldi S
J Heart Valve Dis; 1998 May; 7(3):283-91. PubMed ID: 9651841
[TBL] [Abstract][Full Text] [Related]
12. Influence of polyethylene glycol graftings on the in vitro degradation and calcification of bovine pericardium.
Vasudev SC; Chandy T; Sharma CP
J Biomater Appl; 1997 Apr; 11(4):430-52. PubMed ID: 9178094
[TBL] [Abstract][Full Text] [Related]
13. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
Neethling WM; Hodge AJ; Clode P; Glancy R
J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
[TBL] [Abstract][Full Text] [Related]
14. In vivo study of lyophilized bioprostheses: 3 month follow-up in young sheep.
Taniguchi FP; Maizato MJ; Ambar RF; Pitombo RN; Leiner AA; Moreira LF; Cestari IA; Stolf NA
Rev Bras Cir Cardiovasc; 2012 Dec; 27(4):592-9. PubMed ID: 23515732
[TBL] [Abstract][Full Text] [Related]
15. Inorganic-polymerization crosslinked tissue-siloxane hybrid as potential biomaterial for bioprosthetic heart valves.
Yang F; He H; Xu L; Jin L; Guo G; Wang Y
J Biomed Mater Res A; 2021 May; 109(5):754-765. PubMed ID: 32681740
[TBL] [Abstract][Full Text] [Related]
16. Improved biocompatibility of bioprosthetic heart valves by L-glutamic acid treatment.
Grimm M; Grabenwöger M; Eybl E; Moritz A; Böck P; Müller MM; Wolner E
J Card Surg; 1992 Mar; 7(1):58-64. PubMed ID: 1348195
[TBL] [Abstract][Full Text] [Related]
17. Hybrid Pericardium with VEGF-Loaded Hyaluronic Acid Hydrogel Coating to Improve the Biological Properties of Bioprosthetic Heart Valves.
Lei Y; Deng L; Tang Y; Ning Q; Lan X; Wang Y
Macromol Biosci; 2019 Jun; 19(6):e1800390. PubMed ID: 30951253
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of an acellular bovine pericardium intended for manufacture of valve bioprostheses.
Goissis G; Giglioti Ade F; Braile DM
Artif Organs; 2011 May; 35(5):484-9. PubMed ID: 21595716
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of Vivere bovine pericardium valvular bioprosthesis with a new anti-calcifying treatment.
Braile-Sternieri MCVB; Goissis G; Giglioti AF; Ramirez VDA; Pereira NP; de Vasconcellos A; Basso-Frazzato GG; Braile DM
Artif Organs; 2020 Nov; 44(11):E482-E493. PubMed ID: 32364253
[TBL] [Abstract][Full Text] [Related]
20. Mapping of glutaraldehyde-treated bovine pericardium and tissue selection for bioprosthetic heart valves.
Simionescu D; Simionescu A; Deac R
J Biomed Mater Res; 1993 Jun; 27(6):697-704. PubMed ID: 8408100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
